ARCHIVES

Varmus Discusses Grant Policy, Changes in Congress and Ebola

This article is from The Cancer Letter archive.

Vol. 40 No. 46 | December 12, 2014

Download PDF Visit The Full Archive

Related Articles

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

NCAB Member Becker Says AACR ‘Feels Disenfranchised’

December 6, 1991

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Report Outlines “Grand Challenges” For Chemistry

March 7, 2003